Package 50090-6581-3

{"route": ["ORAL"], "spl_id": "2505ce8d-2867-49e4-a2bb-2ca1188af4d4", "openfda": {"unii": ["G447S0T1VC"], "rxcui": ["313565"], "spl_set_id": ["659a7c36-378a-4392-bb13-948337caf17f"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "10 TABLET in 1 BOTTLE (50090-6581-0)", "package_ndc": "50090-6581-0", "marketing_start_date": "20230807"}, {"sample": false, "description": "14 TABLET in 1 BOTTLE (50090-6581-1)", "package_ndc": "50090-6581-1", "marketing_start_date": "20230807"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (50090-6581-2)", "package_ndc": "50090-6581-2", "marketing_start_date": "20230807"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (50090-6581-3)", "package_ndc": "50090-6581-3", "marketing_start_date": "20230807"}], "brand_name": "Valacyclovir", "product_id": "50090-6581_2505ce8d-2867-49e4-a2bb-2ca1188af4d4", "dosage_form": "TABLET", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "50090-6581", "generic_name": "Valacyclovir", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Valacyclovir", "active_ingredients": [{"name": "VALACYCLOVIR HYDROCHLORIDE", "strength": "500 mg/1"}], "application_number": "ANDA209553", "marketing_category": "ANDA", "marketing_start_date": "20230214", "listing_expiration_date": "20261231"}